Arnall Golden Gregory LLP

On October 16, the FTC voted to approve the Negative Option Rule, also known as the “click-to-cancel” rule, which would require that companies make it as easy to cancel a subscription as it is to sign up for one. In a new client alert, AGG Payment Systems & Fintech co-chair Theresa Kananen provides an overview of the rule, the key provisions, penalties for violation, and whether the rule will stand if challenged in court. Learn more: https://lnkd.in/e2izdg-D

AGG Healthcare Authority Newsletter - October 16, 2024 | https://lnkd.in/eVwCxzqU

On October 17, Rich Cleland, AGG Litigation and Intellectual Property of counsel, will present on the panel “Under the Influence: Developing Strategies to Monitor Influencers and Mitigate Enforcement Action” at the Food and Drug Law Institute (FDLI) Advertising & Promotion for Medical Products Conference. Join FDLI at the Westin Hotel in Washington, D.C. or attend virtually. This session will cover essential strategies for conducting background checks, drafting clear contractual requirements, and developing effective influencer monitoring programs. This conference is a must-attend for anyone involved in the advertising and promotion of medical products. Don’t miss out — use discount code AP15 for 15% off registration: https://lnkd.in/exT2X7Rm

Last call to register for tomorrow's complimentary webinar hosted by AGG Food & Drug attorneys Alan Minsk and Laura Dona from 12-1 p.m. EDT. Alan and Laura will discuss recent FDA Notices of Violations and Warning Letters issued to life sciences companies, the agency’s guidance on correcting misinformation, and emerging issues in PRC and MLR reviews. Register now: https://lnkd.in/eVYW_RKv

In an article for Innovation & Tech Today, AGG Privacy & Cybersecurity attorneys Jacqueline Cooney and Erin Doyle discuss the rising risks facing streaming services related to cybersecurity breaches and the theft of intellectual property. “Companies can certainly pursue actions against an entity that illegally distributes content protected under copyright law or commits other types of IP theft,” said Jackie and Erin. “However, in addition to aggressively pursuing bad actors, companies should also be taking steps to ensure that their IP is protected in the same way that personal data or any other critical asset is protected.” Learn more: https://lnkd.in/exS4QKGh

Don’t miss the opportunity to join AGG Food & Drug attorneys Alan Minsk and Laura Dona on October 15 from 12-1 p.m. EDT for a complimentary webinar! Alan and Laura will discuss recent FDA Notices of Violations and Warning Letters issued to life sciences companies, the agency’s guidance on correcting misinformation, and emerging issues in PRC and MLR reviews. Mark your calendar and join the conversation on these important topics: https://lnkd.in/eNQmcxUU

AGG is proud to be a part of the Mobilize Recovery Bus Tour! Mobilize Recovery Across America launched in September and has traveled across the country, stopping today at our Washington, D.C. office. We welcomed local policy members, response supporters, and community trainers. All were invited to sign the Mobilize Recovery bus. AGG Healthcare Litigation partner Rich Collins is moderating the Mobilize Recovery D.C. Roundtable: Now Is the Time, which is being live streamed in partnership with iHeartMedia, Meta, and Substance Abuse and Mental Health Services Administration (SAMHSA). ? Tune in here: https://lnkd.in/e_xT5cf4 #MobilizeRecovery

?? Reminder: Join Us for a Real Estate Litigation Breakfast Briefing! On November 7, join David Marmins, leader of AGG’s Real Estate Litigation team, as he moderates a breakfast briefing featuring a panel discussion on the complexities and disputes in commercial real estate redevelopment at our Atlanta office from 7:30-9 a.m. Panelists will provide a practical look at issues across various sectors, including retail, industrial, office, and multifamily properties. We look forward to hearing insights from: ? Jason Edwards, General Counsel, EDENS ? Parker Haren, Operations Manager, Brasfield & Gorrie, LLC ? Emily White, Senior VP, Industrial PM, JLL Register now to secure your spot: https://lnkd.in/eAWFv_kV

Jason E. Bring and Brian Stimson, AGG Healthcare partners, share insights in a Healthcare IT News article discussing the Supreme Court's recent decision in Loper Bright Enterprises v. Raimondo, which overturned the Chevron doctrine. “It is no longer sufficient for an agency to publish a rule setting forth an interpretation of a statute that is not arbitrary or capricious,” said Jason and Brian. “The agency must now show that its interpretation is the best one.” Read more: https://lnkd.in/e7Gpcg_f

On August 14, the United States District Court for the District of Delaware vacated a $107.5 million jury verdict in Wyeth LLC v. AstraZeneca Pharmaceuticals LP and AstraZeneca AB, ruling the asserted patent claims invalid due to lack of enablement and lack of written description. The court found that the patents did not provide adequate guidance for safely administering the claimed pharmaceutical compounds, particularly when toxic dosages might be necessary for therapeutic effects. For further insights, check out a recent client alert from AGG Intellectual Property partner Matthew Zapadka and AGG patent agent John Schneible, Ph.D. https://lnkd.in/eKrp_kGY